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Abstract
Diabetes is the fastest growing chronic disease condition globally. Type 2 diabetes in particular, has
reached epidemic proportions, with the greatest burden falling on socially disadvantaged groups and
Indigenous peoples.
This review focuses primarily on type 2 diabetes among Aboriginal and Torres Strait Islander people,
which is responsible for the majority of cases of diabetes in this population. It provides general
information on the social and cultural context of diabetes, and the behavioural and biomedical factors
that contribute to diabetes among Aboriginal and Torres Strait Islander people.
This review provides detailed information on:
• the extent of diabetes among Aboriginal and Torres Strait Islander people, including incidence and
prevalence data; hospitalisations; mortality and burden of disease
• the prevention and management of diabetes
• relevant programs, services, policies and strategies that address the health issue of diabetes
among Aboriginal and Torres Strait Islander people
• two special population groups
◦ adolescents
◦ pregnant and post-partum women.
This review concludes by suggesting possible future directions for combatting the growing epidemic of
diabetes among Aboriginal and Torres Strait Islander people.
This review is part of a suite of knowledge exchange products that includes a summary, a video, and a
fact sheet.
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About this review
The purpose of this review is to provide a comprehensive synthesis of key
information on diabetes among Aboriginal and Torres Strait Islander people in
Australia to: (1) inform those involved or interested in Aboriginal and Torres Strait
Islander health; and (2) provide the evidence for those involved in policy, strategy
and program development and delivery. The review focuses primarily on type 2
diabetes among Aboriginal and Torres Strait Islander people- which is responsible
for the majority of cases of diabetes in this population - but also refers to type 1
diabetes and gestational diabetes where relevant. It provides general information
on the social and cultural context of diabetes, and the behavioural and biomedical
factors that contribute to diabetes among Aboriginal and Torres Strait Islander
people. This review provides detailed information on the extent of diabetes among
Aboriginal and Torres Strait Islander people, including: incidence and prevalence
data; hospitalisations; mortality and burden of disease. This review discusses the
prevention and management of diabetes, and provides information on relevant
programs, services, policies and strategies that address the health issue of
diabetes among Aboriginal and Torres Strait Islander people. It discusses the
diabetes situation in two special population groups – (i) adolescents and (ii)
pregnant and post-partum women. This review concludes by suggesting possible
future directions for combatting the growing epidemic of diabetes among Aboriginal
and Torres Strait Islander people.
This review uses information taken from journal articles, research reports,
government reports, national data collections and national surveys that are
available and can be accessed through the Australian Indigenous HealthInfoNet’s
publication database https://healthinfonet.ecu.edu.au/key-resources/publications/.
The HealthInfoNet, consistent with its nomenclature guide, prefers the term
‘Aboriginal and Torres Strait Islander’ rather than ‘Indigenous Australian’ for its
publications. Also, some sources may only use the terms ‘Aboriginal only’ or
‘Torres Strait Islander only’. However, when referencing information from other
sources, authors may use the terms from the original source. As a result, readers
may see these terms used interchangeably in some instances. If they have any
concerns, they are advised to contact the HealthInfoNet for further information.
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Introduction
Diabetes is the fastest growing chronic disease condition globally (Diabetes Australia,
2015a) (Zimmet, 2017). Type 2 diabetes in particular, has reached epidemic proportions.
It is estimated that in 2019, 463 million people had diabetes (International Diabetes
Federation, 2019). This number is projected to reach 578 million by 2030, and 700 million
by 2045, although these are probably underestimates (Zimmet, 2017). Diabetes
prevention poses a challenge for public health systems everywhere (Diabetes Australia,
2015a; Shaw & Tanamas, 2012; Zimmet et al., 2014). The greatest burden tends to fall
on socially disadvantaged groups and indigenous peoples (Zimmet et al., 2014).
Aboriginal and Torres Strait Islander Australians experience disproportionately high levels
of diabetes. They are almost three times more likely to have diabetes than nonIndigenous Australians (Australian Bureau of Statistics, 2019). Although Aboriginal and
Torres Strait Islander women are no more likely to develop gestational diabetes
(Australian Institute of Health and Welfare, 2020c), they are more likely to have preexisting diabetes than non-Indigenous women (Australian Institute of Health and Welfare,
2021c). There is also evidence that Aboriginal and Torres Strait Islander children younger
than 17 years of age are between 6 and 20 times more likely to develop type 2 diabetes
(Craig et al., 2007; Haynes et al., 2016) (traditionally considered an adult condition) than
non-Indigenous children. Mortality rates are correspondingly high, and Aboriginal and
Torres Strait Islander people are four times more likely to die from diabetes than nonIndigenous Australians (Australian Institute of Health and Welfare, 2020c).
The high level of diabetes among Aboriginal and Torres Strait Islander people reflects
a broad range of contributing factors (Australian Government Department of Health,
2021b; Australian Institute of Health and Welfare, 2015b; Diabetes Australia, 2013a).
These include education, employment, income, housing, access to services, connection
with land, racism and incarceration (Carson et al., 2007; Marmot, 2004). Addressing
these factors should reduce the impact of diabetes on Aboriginal and Torres Strait
Islander people; but this will require a range of tailored, culturally appropriate prevention
and management programs, and broader action beyond the health service sector
(Australian Government Department of Health, 2021b; Closing the Gap Clearinghouse,
2012; Diabetes Australia, 2013a; O'Dea et al., 2007).
Prevention, early detection and management are critical for reducing the impact of
diabetes on Aboriginal and Torres Strait Islander people. It is important that programs for
Aboriginal and Torres Strait Islander people are delivered sensitively, tailored to
community needs, and not perceived as being forced upon communities (Diabetes
Australia, 2013a). In addition, the involvement of Aboriginal and Torres Strait Islander
community members and Aboriginal Health Practitioners in the design of any programs
will help to ensure that the proposed intervention is culturally acceptable to the wider
community (Nguyen et al., 2016).
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Box 1: Diabetes
Diabetes (diabetes mellitus) is a condition marked by high levels of glucose in the
blood due to the body’s inability to produce and/or use insulin effectively
(Australian Institute of Health and Welfare, 2014c). It is a complex, chronic
condition that can lead to morbidity, disability, reduced quality of life and premature
death (Australian Institute of Health and Welfare, 2014c; Diabetes Australia, 2011;
Shaw & Tanamas, 2012). Diabetes can affect the entire body and typically requires
lifelong management (Diabetes Australia, 2011; Shaw & Tanamas, 2012). New
research has shown it is possible for some people with type 2 diabetes to reduce
their average glucose level to that which is considered ‘normal’ (achieve an HbA1c
of under 6.5% or 48 mmol/mol) and sustain it at that level for a prolonged period of
time (at least three months) - without the need for glucose lowering medication.
This is referred to as type 2 diabetes ‘remission’ (Diabetes Australia, 2021d;
Diabetes UK, 2021; Riddle et al., 2021).
If undiagnosed or suboptimally managed, diabetes can lead to a range of
complications and death (Australian Bureau of Statistics, 2014a). Complications
include diseases of the large blood vessels (macrovascular disease), such as heart
disease and stroke, and diseases of the small blood vessels (microvascular
disease), such as kidney disease, eye disease and nerve disease (Diabetes
Australia, 2015b). Type 2 diabetes is the most common form of diabetes,
traditionally affecting older people but increasingly occurring in young people and
children (Kao & Sabin 2016)(Shaw & Tanamas, 2012; Zimmet et al., 2014). Type 1
diabetes and gestational diabetes are the other main types of diabetes (Australian
Institute of Health and Welfare, 2020a). Other types of diabetes are relatively
uncommon, and are most typically related to certain conditions or syndromes
that result in defects in insulin secretion, insulin action, or both, such as diabetes
after pancreatitis.

The context of Aboriginal and Torres Strait Islander health and
diabetes
The risk of developing type 2 diabetes is influenced not only by an individual’s behaviour,
but primarily by historical, social, cultural, geographical, economic and community factors,
and government health policies and services (Closing the Gap Clearinghouse, 2012;
Zimmet, 2017). Health disparities experienced by indigenous peoples worldwide are
influenced by the continuing impact of colonialism which has had lasting effects on health
determinants and access to health services (Tremblay et al., 2020). In particular health
service programs and health-care practices are generally based on dominant group
values, principles and beliefs, often leading to stigmatisation and racism within these
systems. Emerging evidence suggests that epigenetic factors, the intrauterine
environment and other early life factors may also influence the development of diabetes
(McEwen et al., 2019; Zimmet et al., 2014).
Several behavioural and biomedical factors are known to increase the risk of
developing type 2 diabetes, (Australian Institute of Health and Welfare, 2015c);
conversely, improvements in these factors can reduce the risk of type 2 diabetes and
become protective in nature. The main health risk factors are discussed below.
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Factors contributing to diabetes among Aboriginal and Torres Strait
Islander people
Protective factors
There are no known protective factors against type 1 diabetes but beneficial changes in
lifestyle, such as a reduction in obesity, increases in physical activity and improvements
in diet, are critical to reducing the risk of type 2 diabetes and have been well documented
(Australian Institute of Health and Welfare, 2015c, 2020c; Closing the Gap
Clearinghouse, 2012).
Breastfeeding can be protective against the development of type 2 diabetes for both
the mother and offspring. Numerous studies have shown that breastfeeding can reduce
the risk of maternal type 2 diabetes in later life (Horta & de Lima, 2019), and reduce the
rate of progression from gestational diabetes to type 2 diabetes (Chamberlain et al.,
2016). Breastfeeding may also reduce the risk of babies becoming overweight (Diabetes
Australia, 2013a).

Risk factors
Behavioural and biomedical risk factors known to increase the risk of developing type 2
diabetes include high blood pressure, tobacco smoking, low levels of physical activity,
poor diet (high in sodium, sugar and saturated fats), and having overweight or obesity
(Australian Institute of Health and Welfare, 2015c, 2020c) (See Box 2). Aboriginal and
Torres Strait Islander people are more likely to have these risk factors for diabetes than
non-Indigenous Australians (Australian Bureau of Statistics, 2014e), and many who
already have diabetes have multiple risk factors and other related health conditions
(Australian Bureau of Statistics, 2014c, 2014d; Australian Institute of Health and Welfare,
2014b).
In contemporary society, economic opportunity, physical infrastructure and social
conditions influence the health of individuals and communities (Carson et al., 2007;
Marmot, 2004; Wilkinson & Marmot, 2003). These factors are apparent in measures of
education, employment, income, housing, access to services, connection with land,
racism and incarceration. On all these measures, Aboriginal and Torres Strait Islander
people experience substantial disadvantage in comparison with non-Indigenous
Australians.
The high prevalence of many risk factors among Aboriginal and Torres Strait Islander
people is well documented, and is likely to contribute to the high prevalence of diabetes in
this population compared with the non-Indigenous population (Closing the Gap
Clearinghouse, 2012).

https://ro.ecu.edu.au/aihjournal/vol3/iss2/1
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Box 2: Health risk factors for diabetes
Health risk factors refer to the behaviours, characteristics, or exposures that
increase the likelihood of a person developing a disease (Australian Institute of
Health and Welfare, 2015c, 2020c). When people have multiple risk factors, the
likelihood of developing the disease is heightened. Risk factors can also increase
the severity of the disease and the likelihood of developing complications or other
diseases, and can compromise efforts to provide optimal care to people who
already have the disease.
The conventional risk factors for diabetes can be divided into two main
categories: non-modifiable and modifiable (Australian Institute of Health and
Welfare, 2008, 2015c). Non-modifiable risk factors include family history and age.
Modifiable risk factors can be categorised as behavioural or biomedical and can be
modified by changes in behaviour and lifestyle, or the use of medical interventions.
Behavioural risk factors are health-related behaviours and include tobacco
smoking, low levels of physical activity and inadequate nutrition. Biomedical risk
factors are often influenced by behavioural risk factors, but refer to factors that are
present in the body and include impaired glucose regulation, high blood pressure
(hypertension), high blood cholesterol (dyslipidaemia) and obesity. When these risk
factors occur together, known collectively as the metabolic syndrome, they greatly
increase the risk of type 2 diabetes.
Having more than one risk factor increases the risk of diabetes and having
diabetes increases the risk of some other diseases including cardiovascular
disease, kidney disease and diabetic retinopathy (Australian Institute of Health and
Welfare, 2012, 2015c). Cardiovascular disease is itself a risk factor for diabetes.

Epigenetics and the intrauterine environment
Evidence is now emerging as to the influence of epigenetics and the intrauterine
environment on diabetes incidence. We know that mothers with pre-existing type 2
diabetes and mothers with gestational diabetes (GDM) are more likely to have offspring
who develop diabetes later in life and this is believed to be due to changes in the
offspring’s gene expression (Zimmet, 2017).
Epigenetics, or changes in gene expression, due to stressors in the intrauterine
environment during critical periods of fetal development, may be the mechanism by which
the development of diabetes occurs (Ling & Rönn, 2019; McEwen et al., 2019; Zimmet,
2017). The developmental origins of health and disease (DOHaD) hypothesis proposes
that babies who face intrauterine stressors such as diabetes risk factors (maternal
malnutrition, maternal psychological stress, smoking and alcohol use) and hyperglycemia
during pregnancy, experience epigenetic changes that predispose them to poor physical
and neurocognitive health (McEwen et al., 2019).
Both low birth weight (<2500 grams) and high birth weight (> 4000 grams) are risk
factors for the development of type 2 diabetes and obesity later in life (Hare et al., 2020).
In 2019, 12% of Aboriginal and Torres Strait Islander births were low birth weight
compared with an Australian average of 6.6% (Australian Institute of Health and Welfare,
2019a). The mean birth weight for Aboriginal and Torres Strait Islander babies was 3,211
grams, compared with an Australian average of 3,321 grams. These results are likely to
be explained by the high prevalence of risk factors in Aboriginal and Torres Strait Islander
mothers such as poverty, racism and malnutrition (McEwen et al., 2019). A recent study
by Hare and colleagues (Hare et al., 2020) identified that rates of high birthweight and
large-for-gestational-age among births to Aboriginal mothers more than doubled between
1987 and 2016. They suggest that this trend is primarily driven by increasing rates of
hyperglycemia in pregnancy in this population. These figures may partly explain the
higher prevalence of type 2 diabetes among Aboriginal and Torres Strait Islander people.
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Diabetes risk through epigenetic changes can be transmitted inter-generationally thus
creating a vicious cycle that will continue to reinforce the type 2 diabetes epidemic
(Zimmet, 2017).

Box 3: Types of diabetes
Pre-diabetes describes a condition in which blood glucose levels are higher than
normal, although not high enough to be diagnosed as type 2 diabetes (fasting
blood glucose levels between 5.5 and 6.9 mmol/l) (Diabetes Australia, 2016). Prediabetes has no signs or symptoms. People with pre-diabetes have a higher risk of
developing type 2 diabetes and cardiovascular disease. Pre-diabetes can often be
prevented from progressing to diabetes through lifestyle changes and weight loss.
There are two pre-diabetes conditions: impaired glucose tolerance (IGT) and
impaired fasting glucose (IFG) (Diabetes Australia, 2016).
Type 1 diabetes is most frequently diagnosed in childhood and adolescence
(Australian Institute of Health and Welfare, 2010, 2014b; World Health
Organization, 2012). It is an autoimmune condition that is characterised by
hyperglycaemia (high blood sugar levels) resulting from the body’s inability to
produce insulin.
Type 2 diabetes traditionally develops in adulthood, although the incidence is
increasingly reported in child and adolescent populations (Kao & Sabin, 2016). As
with pre-diabetes, there are often no symptoms for type 2 diabetes. It is
characterised by hyperglycaemia due to insulin resistance and/or a deficiency in
insulin production. Type 2 diabetes is managed with lifestyle modifications, and
may require medications and insulin treatment.
Gestational diabetes (GDM) is a form of diabetes that develops during pregnancy
in some women (Australian Institute of Health and Welfare, 2010, 2014b; World
Health Organization, 2012). This type of diabetes is short-term and usually
develops in the second or third trimester of pregnancy, with potentially adverse
outcomes for both mother and baby (Australian Institute of Health and Welfare,
2010, 2014b). GDM usually disappears after the baby is born, although it puts the
mother and child at increased risk of developing type 2 diabetes later in life
(Whitbread et al., 2017). GDM can recur in later pregnancies.
Diabetes in pregnancy (DIP) (or Overt diabetes) is pre-existing type 2 diabetes that
is not diagnosed before pregnancy (International Association of Diabetes and
Pregnancy Study Groups Consensus Panel, 2010). It is important to detect DIP as
early as possible to restore normal glycemia to enable the best posssible
pregnancy outcome. Evidence suggests that Aboriginal and Torres Strait Islander
women with DIP are at high risk of progression to type 2 diabetes within a short
timeframe after birth (Wood et al., 2021).

Extent of diabetes among Aboriginal and Torres Strait Islander
people
There are several types of diabetes, of which the most frequently occurring are type 1,
type 2 and GDM (see Box 3) (Diabetes Australia, 2013b, 2015a; Lalor et al., 2014).
There are various ways to measure the extent of diabetes in a given population,
including prevalence, incidence, health service utilisation, mortality and burden of
disease. This review focuses primarily on national data that provide an aggregate picture
of the impact of diabetes on Aboriginal and Torres Strait Islander people. Much of the
published data pertains to type 2 diabetes, given type 2 diabetes is responsible for the
vast majority of the burden of diabetes, but figures for type 1 diabetes and GDM are
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reported where relevent. If the type of diabetes is not specified it can be assumed to be
type 2 diabetes. Separate data for Torres Strait Islander people is limited, but is also
provided where available.
The various measurements used in this review are defined in Box 4. It should be
noted however, that:
•

the availability and quality of data varies

•

there are data limitations associated with each of the measures of diabetes

•

statistics about diabetes for Aboriginal and Torres Strait Islander people are often
underestimated (Appendix 1 provides a brief discussion of limitations associated
with data sources used in this review).

Box 4: Measuring diabetes
Incidence is the number of new cases of diabetes that occur during a given period
(Lee-Koo et al., 2014).
Prevalence is the number or proportion of cases of diabetes in a population at a
given time (Lee-Koo et al., 2014).
Age-standardised rates enable comparisons of rates of diabetes between
populations that have different age structures (Steering Committee for the Review
of Government Service Provision, 2014a). Age standardisation is often used when
comparing Aboriginal and Torres Strait Islander people and non-Indigenous people
because the Aboriginal and Torres Strait Islander population has a younger age
structure than the non-Indigenous population.
Rate ratio is the rate of Aboriginal and Torres Strait Islander people affected by
diabetes divided by the rate of non-Indigenous people affected by diabetes
(Steering Committee for the Review of Government Service Provision, 2014a).
Ratio is the proportion of Aboriginal and Torres Strait Islander people affected by
diabetes divided by the proportion of non-Indigenous people affected by diabetes.
Potentially preventable hospitalisations are hospital admissions for conditions
(including diabetes) that may have been avoided through appropriate preventive
measures and early disease management, usually delivered in primary care and
community based care settings (Steering Committee for the Review of Government
Service Provision, 2014a).
Potentially avoidable deaths are deaths among people aged less than 75 years from
conditions (including diabetes) considered potentially preventable and treatable
(Steering Committee for the Review of Government Service Provision, 2014a).
Potentially avoidable deaths can be reduced through lifestyle improvements and
appropriate primary prevention, early intervention and medical treatment.
Burden of disease is measured in disability-adjusted life years (DALYs). It provides
a combined estimate of years of life lost due to premature mortality caused by
diabetes, and years of life lost due to disability or ill health caused by diabetes
(Australian Institute of Health and Welfare, 2015a).

Prevalence
In 2018, there were 208 cases of type 1 diabetes per 100,000 population among
Aboriginal and Torres Strait Islander children and young adults aged 0–24 years. After
adjusting for age, Aboriginal and Torres Strait Islander children and young adults were
less likely to have type 1 diabetes than non-Indigenous children and young adults (197
per 100,000 and 232 per 100,000 respectively) (Australian Institute of Health and
Welfare, 2020c).
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According to self-reported data from the ABS 2018-19 National Aboriginal and Torres
Strait Islander Health Survey1 (NATSIHS), around 7.9% of Torres Strait Islander people
and 7.8% of Aboriginal people had diabetes2 (combined total proportion 7.9% or 64,100
people) (Australian Bureau of Statistics, 2019). After controlling for differences in the age
structures between the populations, based on self-reported and measured results,
Aboriginal and Torres Strait Islander people were 2.9 times as likely to have diabetes as
non-Indigenous Australians (13% compared with 4.3%) (Australian Bureau of Statistics,
2019). The proportion was similar in males and females after age-standardisation (13%
and 12% respectively).
The prevalence of diabetes increased with age, (Australian Bureau of Statistics,
2019) ranging from 2.5% for Aboriginal and Torres Strait Islander people aged 25-35
years to 11% for those aged 35-44 years, 19% for those aged 45-54 years and 35% for
those aged 55 years and over. While rates among Aboriginal and Torres Strait Islander
people are higher than non-Indigenous people in almost all age groups, this is particularly
true for the younger age groups (25-54 years) (see Table 1).
The rate of diabetes/high sugar levels was higher for both Aboriginal and Torres Strait
Islander males and females than non-Indigenous males and females (2.5 and 3.2 times
higher respectively), but lower among Aboriginal and Torres Strait Islander people living
in non-remote areas (15 per 100 persons) than among those living in remote areas (24
per 100 persons) (see Table 1). Rates of diabetes/high sugar levels varied between
states and territories (Australian Institute of Health and Welfare & National Indigenous
Australians Agency, 2020); they were highest in Western Australia (WA) at 24 per 100
persons, followed by the Northern Territory (NT) at 22 per 100 persons. Tasmania (Tas)
had the lowest rate at 8.5 per 100 persons, with 11 per 100 persons in the Australian
Capital Territory (ACT), 12 per 100 persons in Victoria (Vic), 13 per 100 persons in New
South Wales (NSW), and 20 per 100 persons in both Queensland (Qld) and South
Australia (SA).

1

The National Aboriginal and Torres Strait Islander Health Survey (NATSIHS), run by the ABS, collects
information from Aboriginal and Torres Strait Islander people on health measures. These measures include
statistics about long-term health conditions, disability, lifestyle factors, physical harm and use of health
services Australian Bureau of Statistics. (2019). National Aboriginal and Torres Strait Islander Health
Survey, 2018-19.

2

Self-reported data from the ABS 2018–19 National Aboriginal and Torres Strait Islander Health Survey
does not distinguish between type 1 and type 2 diabetes.
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Table 1. Rates1 of people reporting diabetes/high sugar levels as a long-term health
condition, by Indigenous status, and Indigenous:non-Indigenous rate ratios, Australia, 20172018 and 2018-2019

Aboriginal and Torres
Strait Islander people2
(Rate)

Non-Indigenous3
(Rate)

Rate Ratio4

18-24

0.8

0.9

0.9

25-34

3.0

1.2

2.5

35-44

11

2.5

4.4

45-54

21

5.2

4.0

55+

36

15

2.4

Male

18

7.0

2.5

Female

17

5.3

3.2

Non-remote

15

6.1

2.5

Remote5

24

8.6

2.8

Age (years)

Gender

Remoteness

Notes:
1.
2.
3.
4.
5.

Rates are expressed as number per 100 persons.
Data for Aboriginal and Torres Strait Islander people is from NATSIHS 2018-19.
Data for non-Indigenous Australians is from the National Health Survey 2017-18.
Rate ratio is calculated by dividing the Indigenous rate by the non-Indigenous rate.
The NHS 2017-18 excludes Very Remote areas of Australia and discrete Aboriginal
communities.

Source: Australian Institute of Health and Welfare, 2020 (derived from Table D1.09.2) (Australian
Institute of Health and Welfare & National Indigenous Australians Agency, 2020)

Biomedical data
Biomedical data was not collected in the NATSIHS 2018-19, and therefore cannot be
used to compare or corroborate self-reported results. However, biomedical results from
the 2011-12 AATSIHS broadly confirmed the self-reported results obtained in that survey.
Biomedical data was obtained for a subset of Aboriginal and Torres Strait Islander adults
(18 years and over) who provided blood and urine samples (Australian Bureau of
Statistics, 2014a). Results for fasting plasma glucose levels identified that 1.5% of
Aboriginal and Torres Strait Islander adults had diabetes (fasting blood glucose levels ≥7
mmol/L) but were undiagnosed, and a further 4.7% were at high risk of diabetes due to
high fasting blood glucose levels (5.6-6.9 mmol/L) (Australian Bureau of Statistics,
2014b).
Pre-diabetes
In 2012-13, based on fasting plasma glucose results:
•

4.7% of Aboriginal and Torres Strait Islander adults had pre-diabetes

•

the proportion of Aboriginal and Torres Strait Islander adults with pre-diabetes did
not differ significantly by sex or between remote and non-remote areas

•

Aboriginal and Torres Strait Islander adults were 1.8 times as likely to have prediabetes than non-Indigenous adults (based on age-standardised rates)
(Australian Institute of Health and Welfare, 2015d).
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Incidence
Type 1 diabetes
National incidence data for diabetes is based on estimates for insulin-treated diabetes
and obtained from the National (insulin-treated) diabetes register (NDR). This data is
limited to type 1 diabetes incidence for Aboriginal and Torres Strait Islander people
(Australian Institute of Health and Welfare, 2020b).
In 2019, there were 130 new cases of type 1 diabetes among Aboriginal and Torres
Strait Islander people, accounting for 4% of all new cases (Australian Institute of Health
and Welfare, 2020b). Of these, the age-standardised rate per 100,000 population was 16
for males and 9.8 for females. The incidence rate for Aboriginal and Torres Strait Islander
people was similar to that for non-Indigenous people (13 per 100,000 population
compared with 12 per 100,000 population respectively).
A prospective population-based incidence study conducted in NSW between 20012006 (Craig et al., 2007) found that incidence rates of type 1 diabetes were similar in the
Aboriginal and Torres Strait Islander and non-Indigenous youth aged 19 years or younger
(16 per 100,000 and 21 per 100 000 respectively).
Gestational diabetes
In 2017-18, over 1,700 (13%) Aboriginal and Torres Strait Islander mothers who gave
birth were diagnosed with GDM. After adjusting for differences in the age structure of the
populations, the incidence rate among Aboriginal and Torres Strait Islander mothers was
similar to the rate for non-Indigenous mothers (17% and 16% respectively) (Australian
Institute of Health and Welfare, 2020c). By contrast, just over 2% of Aboriginal and Torres
Strait Islander mothers and less than 1% of non-Indigenous mothers who had a baby in
2016-2018 reported that they had pre-existing diabetes (Australian Institute of Health and
Welfare, 2021c).
In 2016-17 (Australian Institute of Health and Welfare, 2019c):
•

there were over 1,600 new cases of GDM among Aboriginal and Torres Strait
Islander women, equating to 12% of Aboriginal and Torres Strait Islander women
aged 15–49 years who gave birth

•

incidence of GDM increased with age, peaking in the 40 years and over age
group at 32%. Aboriginal and Torres Strait Islander women in this age group
were four times as likely to be diagnosed with GDM as Aboriginal and Torres
Strait Islander women aged 15–19 years and 20–24 years (incidence of 6.6%
and 8.8% respectively).

Morbidity
Health service utilisation
Measures of health service utilisation cannot provide information about whether the
health system is meeting the needs of Aboriginal and Torres Strait Islander people, but
they give some indication of the demand for, and access to, health services (Australian
Institute of Health and Welfare, 2014a). Included among these measures are figures for
attendance at general practices and hospitals.
General practice attendances
General practitioners (GPs) are usually the initial point of contact for people with diabetes
and often play a key role in coordinating the other specialised services and health
professionals who are needed to manage the condition (Australian Institute of Health and
Welfare, 2008). The Bettering the evaluation and care of health (BEACH) survey is a
continuous, national, cross-sectional survey of the clinical activity of GPs (Britt & Miller,
2013). The survey provides some evidence of the frequency with which GPs manage
diabetes for Aboriginal and Torres Strait Islander patients.
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Data from the Bettering the Evaluation and Care of Health (BEACH) study indicate that,
in the period from April 2010 to March 2015, 5.5% of problems managed by GPs among
Aboriginal and Torres Strait Islander people, were diabetes related. The majority of
diabetes-related problems managed were for non-insulin dependent type 2 diabetes (92%).
The rate of diabetes problems managed by GPs was three times as high among Aboriginal
and Torres Strait Islander people as among other Australians. The disparity was greater for
non-insulin dependent type 2 diabetes than insulin dependent type 1 diabetes (3 and 2.3
times respectively) (Australian Institute of Health and Welfare, 2020c).
As at June 2019, over half (56%) of Aboriginal and Torres Strait Islander regular
clients with type 2 diabetes had claimed a GP Management Plan in the previous 2 years,
while 53% had claimed a Team Care Arrangement (Australian Institute of Health and
Welfare, 2020c). The proportion of Aboriginal and Torres Strait Islander regular clients
claiming either a GP Management Plan or Team Care Arrangement in the previous 2
years increased slightly from June 2017 to June 2018 (54% to 56% for GP Management
Plans and 51% to 53% for Team Care Arrangements) though remained unchanged from
June 2018 to June 2019 .

Hospitalisation
Hospital services are typically required to treat the advanced stages of complications of
diabetes or acute episodes of hyper- or hypoglycaemia (Australian Institute of Health and
Welfare, 2014b). The higher levels of diabetes observed among Aboriginal and Torres
Strait Islander people are clearly reflected in hospitalisation figures.

Type 1
In 2017-18, national hospitalisation data showed (Australian Institute of Health and
Welfare, 2020c):
•

there were around 3,000 hospitalisations with a principal and/or additional
diagnosis of type 1 diabetes among Aboriginal and Torres Strait Islander people,
equating to 361 per 100,000 population

•

the age-standardised rate of hospitalisations for type 1 diabetes in this cohort
increased from 362 to 446 hospitalisations per 100,000 population between 201516 and 2017-18

•

after adjusting for age, the hospitalisation rate was almost twice as high among
Aboriginal and Torres Strait Islander people compared with non-Indigenous
people (446 per 100,000 and 233 per 100,000 respectively)

•

the age-standardised hospitalisation rate was higher among Indigenous males
than females (525 hospitalisations per 100,000 and 381 hospitalisations per
100,000 population respectively)

•

age-specific hospitalisation rates peaked in those aged 55–64 years (905
hospitalisations per 100,000 population)

•

hospitalisation rates for type 1 diabetes as a principal and/or additional diagnosis
were around three times as high among Aboriginal and Torres Strait Islander people
living in major cities and regional areas as those living in remote and very remote
areas (482, 528 and 175 hospitalisations per 100,000 population respectively)

•

among the states and territories, hospitalisation rates were highest in Vic (575 per
100,000 population) and lowest in the NT (147 per 100,000 population). Other
states had rates ranging from 322 to 562 per 100,000 population.

Published by Edith Cowan University, 2022

11

Journal of the Australian Indigenous HealthInfoNet, Vol. 3 [2022], Iss. 2, Art. 1

Type 2
In 2017-18, national hospitalisation data showed (Australian Institute of Health and
Welfare, 2020c):
•

there were around 69,000 hospitalisations with a principal and/or additional
diagnosis of type 2 diabetes among Aboriginal and Torres Strait Islander adults

•

the age-standardised hospitalisation rate was almost five times as high among
Aboriginal and Torres Strait Islander adults as non-Indigenous adults (19,000 per
100,000 and 4,500 per 100,000 population respectively)

•

the age-standardised rate of hospitalisations increased from 12,100
hospitalisations per 100,000 population to 14,300 hospitalisations per 100,000
population between 2015-16 and 2017-18

•

after adjusting for age, the hospitalisation rate was higher among Aboriginal and
Torres Strait Islander females (all ages) compared to Aboriginal and Torres Strait
Islander males (15,500 per 100,000 and 13,100 per 100,000 population
respectively) (Table 2)

•

type 2 diabetes hospitalisation rates increased with age, peaking in those aged
65 years of age and over (45,800 hospitalisations per 100,000 population)

•

hospitalisations for type 2 diabetes were 3.3 times as high among Aboriginal and
Torres Strait Islander people living in remote and very remote areas as those
living in major cities (30,800 compared with 9,200 per 100,000 population)

•

hospitalisation rates were highest in WA (35,000 per 100,000 population) and
lowest in Tas (4,100 per 100,000 population). Other states and territories had
rates ranging from 6,200 to 21,800 per 100,000 population.

Table 2: Rate ratio of hospital separations for diabetes1 for Aboriginal and Torres Strait Islander
people and non-Indigenous people (as a principal diagnosis), by age group and sex, 2017-18

Males

Females

Age group (years)
Rate Ratio

Persons
2,3

0-4

0.8

1.8

1.3

5-14

1.3

1.5

1.4

15-24

1.7

3.6

2.9

25-34

3.5

5.1

4.5

35-44

5.4

7.5

6.6

45-54

4.6

6.5

5.3

55-64

3.6

5.3

4.2

65+

2.6

4.0

3.1

Total

1.8

3.4

2.5

Notes:
1.
2.
3.

Based on the ICD-10-AM 10th edition codes E10, E11, E13, E14, O24.
Rates age standardised to the 2001 Australian population.
Rate ratio is the Indigenous rate (number per 100,000 population) divided by the nonIndignous rate.

Source: AIHW analysis of National Hospital Morbidity Database (Australian Institute of Health and
Welfare, 2020c)
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Mortality
In 2020, the rate of deaths from diabetes for Aboriginal and Torres Strait Islander people
was 75 per 100,000 population. This rate was 4.9 times higher than for non-Indigenous
people (Australian Bureau of Statistics, 2021). The death rate was higher for Aboriginal
and Torres Strait Islander males than females (82 per 100,000 and 71 per 100,000
respectively). Diabetes was the fourth leading cause of death for Aboriginal and Torres
Strait Islander males and the second leading cause of death for females.
Between 2011-2015 and 2016-2020, the number of Aboriginal and Torres Strait
Islander people dying from diabetes decreased from 81 deaths per 100,000 population to
75 per 100,000 population (Australian Bureau of Statistics, 2021).
The greatest disparity in Aboriginal and Torres Strait Islander: non-Indigenous agespecific death rates in 2020 occurred in the 45-54 years age group (Australian Bureau of
Statistics, 2021). In this age group Aboriginal and Torres Strait Islander people were 10.7
times more likely to die from diabetes than non-Indigenous people (rate ratios were 16.6
for females and 8.1 for males).
In the period 2014-2018, the age-standardised rate of avoidable and preventable deaths3
from diabetes was 44 per 100,000 population among Aboriginal and Torres Strait Islander
people (Australian Institute of Health and Welfare, 2020c). After adjusting for age, the
rate was similar among males and females (46 per 100,000 population and 42 per
100,000 population respectively). The rate of avoidable and preventable deaths from
diabetes increased with age for both Aboriginal and Torres Strait Islander males and
females (Table 3). There was variation in the rate of avoidable and preventable deaths
from diabetes by state and territory. The NT had the highest rate (108 per 100,000
population), followed by WA (66 per 100,000 population), Qld and SA (43 per 100,000
population) and NSW (21 per 100,000 population).

3

Avoidable and preventable mortality refers to deaths from conditions that are considered avoidable given
timely and effective health care (including disease prevention and population health initiatives) Australian
Institute of Health and Welfare, & National Indigenous Australians Agency. (2020, 9/12/2020). Aboriginal
and Torres Strait Islander Health Performance Framework report. Australian Institute of Health and
Welfare. https://www.indigenoushpf.gov.au/.
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Table 3. Avoidable and preventable deaths from diabetes1, Aboriginal and Torres Strait
Islander Australians, 2014-2018

Number per 100,000 population
Age group (years)
Males

Females

Persons

0-44

3

3

3

45-49

39

27

33

50-54

71

63

66

55-59

92

105

99

60-64

155

168

162

65-74

281

253

266

Total2

46

42

44

Notes:
1.
2.
3.
4.

ICD Codes E10,E11,E13, E14.
Rates age-standardised to the 2001 Australian Standard Population.
Includes data from NSW, Qld, WA, SA and the NT only.
Rates were calculated using ABS 2016 Census-based population estimates and
projections.
Source: AIHW analysis of National Mortality Database (Australian Institute of Health and Welfare,
2020c)

Burden of disease
Every year in Australia, many years of healthy life are lost because of injury, illness or
premature deaths in the population. This loss of healthy life is called the ‘burden of
disease’ (Australian Institute of Health and Welfare, 2021b).
The Australian burden of disease study (ABDS) measures the impact of living with
illness and injury and dying prematurely. The summary measure ‘disability-adjusted life
years’ (or DALY) measures the years of healthy life lost from death and illness.
In 2018, type 2 diabetes was the fourth-leading specific cause of total burden of
disease among Aboriginal and Torres Strait Islander people, with an age-standardised
rate of 15 DALY per 1,000 people (Australian Institute of Health and Welfare, 2021b).

Special populations
Children and adolescents
There is growing concern regarding the emergence of type 2 diabetes in Aboriginal and
Torres Strait Islander children and adolescents (Zimmet et al., 2014). Data are limited,
but type 2 diabetes accounts for the majority of new cases of youth-onset diabetes4 in this
population; between 2006 and 2011, 55% of new cases in Aboriginal and Torres Strait
Islander youth aged 10-19 years were type 2 and 43% were type 1 diabetes (Australian
Institute of Health and Welfare, 2014d). Type 2 diabetes occurs more frequently among
Aboriginal and Torres Strait Islander adolescents than among their non-Indigenous
counterparts (Craig et al., 2007; Haynes et al., 2016; Stone et al., 2013; Titmuss et al.,
2019), with studies from different Australian states, namely WA, NSW and the NT
reporting similar findings.
A retrospective, cross-sectional study of Aboriginal and Torres Strait Islander youth in
the Top End of Australia in 2016-2017 used primary health care data to estimate the
prevalence of type 2 diabetes. The crude prevalence was 6.7 per 1000 population, with
the youngest reported age at diagnosis being 4.4 years of age. Prevalence was higher for

4

Youth-onset diabetes is defined as that diagnosed before the age of 25 years
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those aged 15-24 years (14 per 1000 population) than those 15 years or younger (1.4 per
1000 population) and higher for females than males (9.4 per 1000 population and 4.2 per
1000 population respectively) (Titmuss et al., 2022).
A retrospective population-based cohort study was undertaken in children aged less
than 17 years who were diagnosed with type 2 diabetes in WA between 1990 and 2012
(Haynes et al., 2016). A 20-fold higher mean incidence was observed in Aboriginal and
Torres Strait Islander children compared with non-Indigenous children, (13 per 100,000
person-years compared with 0.6 per 100,000 person-years) although both groups had
similarly high annual rates of increase. The mean age at diagnosis was 13.3 years, with
12% of children being classified as overweight and 61% obese.
Studies conducted in NSW found similar results (Craig et al., 2007; Tran et al., 2014).
Incidence rates were over six times higher in the Aboriginal and Torres Strait Islander
youth with a median age at diagnosis of 13.5 years (Tran et al., 2014) to 14.5 years
(Craig et al., 2007). Ninety percent of the youth were classified as overweight or obese.
Early onset of type 2 diabetes places these children and adolescents at heightened
risk of comorbidities, diabetes complications and associated premature mortality (MapleBrown et al., 2010; Peña et al., 2020; Titmuss et al., 2019; Viner et al., 2017). Renal
disease, hypertension, dyslipidaemia and depressive symptoms are among the most
common comorbidities and complications (Viner, White & Christie 2017). Glycaemic
control in type 2 diabetes during adolescence deteriorates faster than in adults due to
greater insulin resistance and β-cell dysfunction (Peña et al., 2020).
In 2020, the Australian Paediatric Endocrine Group published guidelines on paediatric
type 2 diabetes (Peña et al., 2020). It provides recommendations on screening,
diagnosis, diabetes education, monitoring including targets, multicomponent healthy
lifestyle, pharmacotherapy, assessment and management of complications and
comorbidities, and transition. There is also a dedicated section on considerations of care
for children and adolescents from indigenous backgrounds in Australia and New Zealand.
Previous to this, health professionals had to refer to adult guidelines, or international
guidelines that did not address care for people from indigenous backgounds.

Pregnant women (Diabetes in pregnancy)
Data from the National Perinatal Data Collection (NPDC) relating to Aboriginal and Torres
Strait Islander mothers who gave birth in Australia during 2019 showed that: 12,272
(86%) did not have diabetes, 1,657 (12%) had GDM, and 312 (2.2%) had pre-existing
5
diabetes (Australian Institute of Health and Welfare, 2021a).
Hospitalisations for diabetes in pregnancy
In 2017-18, around 3,800 Aboriginal and Torres Strait Islander females were admitted to
hospital with a principal and/or additional diagnosis of diabetes during pregnancy, a rate
of 24,700 per 100,000 females aged 10-54 years with a pregnancy outcome. Agestandardised rates were 1.8 times as high among Aboriginal and Torres Strait Islander
females in this cohort as non-Indigenous females (36,300 per 100,000 and 19,800 per
100,000 respectively) (Australian Institute of Health and Welfare, 2020c).
Between 2015-16 and 2016-17, hospitalisation rates increased substantially along
with the level of remoteness. The rate was over two times as high among those living in
remote and very remote areas (44,100 per 100,000 females) as those living in major
cities (20,600 per 100,000 females). Rates were highest in the NT (42,300 per 100,000
population) and lowest in Tas (15,500 per 100,000 population). Other states had rates
ranging from 16,100 to 31,300 per 100,000 population (Australian Institute of Health and
Welfare, 2020c).

5

The National Perinatal Data Collection (NPDC) does not distinguish between type 1 and type 2 diabetes.
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Diabetes in pregnancy can lead to a range of complications for the mother and child
(see Box 5) (Australian Institute of Health and Welfare, 2019b)

Box 5: Risks associated with diabetes in pregnancy
Risks for the child include: pre-term birth, stillbirth, low and high birthweight, longer
stay in hospital, low Apgar score, admission to neonatal intensive care units and
resuscitation (Australian Institute of Health and Welfare, 2010, 2019b). There is
also increased risk of obesity, impaired glucose tolerance (IGT) and type 2
diabetes in early adulthood. Babies of mothers with pre-existing diabetes are at
higher risk of complications than those with GDM.
Risks for the mother include: pre-existing and gestational hypertension, preeclampsia, induced labour, pre-term birth, caesarean section, and longer antenatal
and postnatal stays in hospital; first appearance or progression of complications
including those associated with kidney, eye and cardiovascular diseases.
(Australian Institute of Health and Welfare, 2010, 2019b). Mothers with GDM
experience complications at a lower rate than mothers with pre-existing diabetes.
However, for mothers with GDM there is a risk of recurrent GDM in subsequent
pregnancies and progression type 2 diabetes.

Complications for diabetes in pregnancy
Among Australian women who have diabetes during pregnancy, Aboriginal and Torres
Strait Islander mothers and babies are more likely to experience adverse effects during
pregnancy, labour and delivery than non-Indigenous mothers and babies (Australian
Institute of Health and Welfare, 2019b; Duong et al., 2015). Living in a remote region
appears to increase the risk of an adverse outcome (Duong et al., 2015).
Babies of Aboriginal and Torres Strait Islander mothers with pre-existing diabetes had
higher rates of pre-term birth, stillbirth, low and high birthweight, low Apgar score,
resuscitation, and special care nursery/ neonatal intensive care unit admission, and
stayed longer in hospital, compared with mothers with no diabetes (Australian Institute of
Health and Welfare, 2019b).
Mothers with pre-existing diabetes had higher rates of caesarean section, induced
labour, pre-existing and gestational hypertension, and pre-eclampsia, compared with
mothers with no diabetes. They also had longer antenatal and postnatal stays in hospital
(5 or more days) (Australian Institute of Health and Welfare, 2019b).
In 2016-2018 (Australian Institute of Health and Welfare, 2021c):
•

Aboriginal and Torres Strait Islander mothers who had pre-existing diabetes were
2.3 times more likely to have a stillborn baby, and 1.9 times more likely to
experience a perinatal death than those without diabetes.

•

Aboriginal and Torres Strait Islander women who had pre-existing diabetes prior
to the onset of pregnancy were about 3.3 times as likely to have a pre-term birth
as Aboriginal and Torres Strait Islander women who did not have pre-existing
diabetes before the onset of pregnancy.

•

Aboriginal and Torres Strait Islander women who had GDM were about 1.2 times
as likely to have a pre-term birth as Aboriginal and Torres Strait Islander women
who did not have GDM.

•

Pre-existing diabetes and GDM both increased the risk of Aboriginal and Torres Strait
Islander women having a low birthweight baby (0.8 and 0.5 respectively) compared
with Aboriginal and Torres Strait Islander women who did not have diabetes.

National figures regarding complications of diabetes in pregnancy for Aboriginal and
Torres Strait Islander mothers and babies for the period 2014-2015 are presented in
Table 4.
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Table 4. Selected maternal and infant complications of diabetes among Aboriginal and
Torres Strait Islander women who gave birth, by diabetes in pregnancy status, Australia,
2014-2015 (age-standardised percent and ratio)

Complication

Pre-existing
diabetes

Maternal

%1

Ratio2

%1

Ratio2

%1

9.1

7.1

2.9

2.2

1.3

7.1

1.9

5.7

1.5

3.8

8.2

3.4

4.1

1.7

2.4

40

1.5

42

1.6

27

Antenatal hospital stay 5 or more days5

13

7.8

4.7

2.8

1.7

days6

31

3.0

13

1.3

10

Infant

%1

Ratio2

%1

Ratio2

%1

Pre-term birth7

36

2.5

16

1.1

14

Caesarean section

62

2.2

43

1.5

29

Low birthweight8

17

1.3

9.5

0.7

14

birthweight9

5.1

4.1

2.4

2

1.2

Low Apgar score10

5.6

1.9

2.9

1.0

2.9

Resuscitation11

37

1.8

22

1.1

20

Special Care Nursery (SCN)/Neonatal
Intensive Care Unit (NICU) admission

67

3.0

33

1.5

23

Hospital stay 7-13 days12

16

2.9

7.8

1.4

5.6

Hospital stay 14 days or more12

14

2.8

4.6

1.0

4.8

Pre-existing (chronic) hypertension3
Gestational

hypertension3

Pre-eclampsia3
Pre-term

induction4

Postnatal hospital stay 5 or more

High

No
diabetes

GDM

Notes:
1.

Data are directly age-standardised to the Australian female population aged 15–44 as at
30 June 2001.
2. Ratio is calculated by dividing the percent of women with pre-existing or gestational
diabetes by the percent of women with no diabetes for each group.
3. Due to differences in definitions and methods used for data collections between
jurisdictions, care should be taken when interpreting this data.
4. Labour induced at less than 37 weeks.
5. Women who gave birth in hospital only. Excludes women who gave birth in centres
attached to hospitals.
6. Only includes women who were discharged home. Women who gave birth in hospital only.
Excludes women who gave birth in centres attached to hospitals.
7. Gestational age of live born babies from 20-36 weeks (4 babies of less than 20 weeks
gestational age were also included).
8. Less than 2,500 grams.
9. 4,500 grams and over.
10. Apgar score (at five minutes) of 0-6.
11. Only includes where active resuscitation was undertaken.
12. Only babies who were discharged home are included. Excludes babies who were born in
birth centres attached to hospitals.
Source: Derived from (Australian Institute of Health and Welfare, 2019a)
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COVID-19 and diabetes
The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
virus and the resulting COVID-19 pandemic (Gujral et al., 2020) has highlighted the
vulnerability of those people with diabetes and other non-communicable chronic diseases
(Australian Government Department of Health, 2021b). Among those hospitalised with
COVID-19, patients with diabetes are reportedly among the most severely affected.
According to national data (COVID-19 National Incident Room Surveillance Team, 2020)
people with diabetes experience higher rates of intensive care unit stays and deaths due
to COVID-19. There is also emerging evidence that long-term health consequences and
complications of diabetes are exacerbated by COVID-19, and that COVID-19 may induce
the onset of diabetes (Khunti et al., 2021).
Aboriginal and Torres Strait Islander people and people living in remote communities
are at greater risk of contracting COVID-19 than the general population for several
reasons (Communicable Disease Network Australia, 2020):
•

there are often higher rates of other health issues in these communities

•

it can be harder to access health care

•

people in the community may be very mobile and travel often

•

people often rely more on outreach services in remote places.

Other risk factors for Aboriginal and Torres Strait Islander people include: living in
large households, crowded or insecure housing and/or intergenerational families.
The Australian Government advises that Aboriginal and Torres Strait Islander people
may be at a greater risk of severe illness from COVID-19 (Australian Government
Department of Health, 2021c) than the general population. This is because, at a
population level, Aboriginal and Torres Strait Islander people have a greater burden of
chronic disease than non-Indigenous Australians (Communicable Disease Network
Australia, 2020) and reduced access to the social determinants of health (Thurber et al.,
2021). This places them at higher risk of severe outcomes from a COVID-19 infection as
has been observed in indigenous populations in the USA (Gujral et al., 2020).
During the ‘first wave’ of the pandemic in early 2020, the Australian Government,
following advice from the National Aboriginal Community Controlled Health Organisation
(NACCHO), ordered the closure of remote communities to prevent visitors entering and
bringing the virus to vulnerable community members (Power, 2020). Telehealth was
utilised for checkups and to ensure the Aboriginal and Torres Strait Islander community
members were adhering to their medical plans. In regional and urban areas, Aboriginal
medical services continued to visit their Elders.
In July 2020, the Australian Government released an emergency response plan for
COVID-19, specifically for Aboriginal and Torres Strait Islander people (Australian
Government Department of Health, 2020). The aim was to reduce the likelihood of a case
in an Aboriginal or Torres Strait Islander community and facilitate community
preparedness. The proposed strategies included:
•

maintaining health service provision in the local health facility

•

monitoring vulnerable people with moderate to severe chronic disease and
working with them to identify potential courses of action in the case of infection

•

ensuring care plans are up to date to manage existing conditions such as
hypertension, renal disease, diabetes and cancer

•

ensuring where possible scripts are filled in advance

•

consideration of maximal safe dispensing of medications to minimise traffic
through clinics.

Particular challenges for primary health care services in remote and very remote
communities in managing a COVID-19 outbreak include the risk of an increase in
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mortality from existing chronic diseases, including diabetes, due to staffing reductions,
and the difficulty in maintaining essential services such as chronic disease programs.
Continuation of health care to at‐risk individuals is crucial throughout the pandemic
(Scott et al., 2020). Telehealth is the key for the delivery of care for patients in rural and
remote areas, or during lockdowns. It is important that people with diabetes are educated
regarding self-management of their condition during acute illness, including medication
changes. It is also critical that there is no deterioration in the medical management of
glycaemia and other complications of diabetes, which, if neglected, may result in
increased morbidity and mortality independent of COVID‐19.
In the healthcare system in the United States of America (USA), the need to maintain
glycemic control while reducing patient contact has led to urgent implementation of
improvised protocols for treatment of people with diabetes (Gujral et al., 2020). A lack of
personal protective equipment (PPE), lockdowns, supply disruptions and social
distancing requirements have led to the development of risk-minimisation strategies that
promote more self-management procedures.

Prevention and management of diabetes
The prevention and management of type 2 diabetes is vital to the current and future
health of Aboriginal and Torres Strait Islander people (O'Dea et al., 2007). It is generally
accepted that for type 2 diabetes prevention and management programs to be effective
they require evidence based health promotion measures, public health interventions and
clinical services. It is important that programs for Aboriginal and Torres Strait Islander
people are delivered sensitively, tailored to community needs, and not perceived as being
forced upon communities (Diabetes Australia, 2013a). In addition, the involvement of
Aboriginal and Torres Strait Islander community members and Aboriginal Health
Practitioners in the design of any programs will help to ensure that the proposed
intervention is culturally acceptable to the wider community (Nguyen et al., 2016).
Furthermore, interventions that improve cultural safety for Indigenous people living with
diabetes can also have positive effects on clinical outcomes (Tremblay et al., 2020).
Most primary health care services in Australia play a critical role in the early detection of
diabetes (Stoneman et al., 2014). Improvements in the early detection of undiagnosed
diabetes in the primary health care setting are recommended to facilitate early intervention
and management for Aboriginal and Torres Strait Islander people (Diabetes Australia, 2013a).
Multifactorial interventions for diabetes management are more successful in achieving
positive health outcomes for patients (Gibson & Segal, 2015). Interventions need to occur
within and beyond the health system (including policy action, education, employment and
nutrition), through government and non-government agencies, and need to commence as
early as possible in the life course (Frier et al., 2021; Nguyen et al., 2016; O'Dea et al.,
2007; Seear et al., 2020).
Formal evaluations of long-term diabetes prevention and management programs for
Aboriginal and Torres Strait Islander communities are limited, but the Australian
experience suggests that the current high levels of diabetes among Aboriginal and Torres
Strait Islander people are potentially preventable (O'Dea, 2005).

Prevention
There is currently no known way to prevent type 1 diabetes (Diabetes Australia, 2015c) or
GDM (Mayo Clinic, 2015), but the prevention of type 2 diabetes in high risk individuals is
a critical component of diabetes care (Royal Australian College of General Practitioners,
2014). Type 2 diabetes and social disadvantage are related (Frier et al., 2021) which
means that broader action that extends beyond the health service sector and addresses
the social determinants of Aboriginal and Torres Strait Islander health such as poverty,
culture, racism, employment and education is required (Diabetes Australia, 2013a; Frier
et al., 2021; O'Dea et al., 2007).
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Conventional best practice primary prevention can prevent or delay the onset of type
2 diabetes in high risk individuals by:
•

identifying those at high risk through the use of risk assessment tools

•

delivering education programs

•

promoting lifestyle modifications that focus on increased physical activity, dietary
change and weight loss.

(Australian Government Department of Health, 2021b).
Furthermore, Aboriginal and Torres Strait Islander people can benefit from diabetes
support, education and services (e.g. Aboriginal and Torres Strait Islander Community
Controlled Health Services, where they exist, or culturally competent mainstream
services) as an integral part of their primary health care services (Australian Department
of Health, 2015a). Food security, access to affordable healthier choices and approporiate
facilities to exercise need to be encouraged and facilitated; and family and child health
needs to be improved through pregnancy and early years programs.
Risk assessment and screening
To deliver evidence based prevention programs to high risk Aboriginal and Torres Strait
Islander people they must first be identified through culturally appropriate risk
assessment (Diabetes Australia, 2013a).
The Australian type 2 diabetes risk assessment tool (AUSDRISK) is a non-invasive
assessment that has been developed to facilitate identification of high risk individuals.
However, with the high background prevalence of type 2 diabetes in Aboriginal and
Torres Strait Islander adults, the Royal Australian College of General Practitioners
(RACGP) recommend that blood testing for pre-diabetes or diabetes in conjunction with
other opportunistic screening (such as a cardiovascular risk assessment) should be the
preferred procedure (National Aboriginal Community Controlled Health Organisation &
Royal Australian College of General Practitioners, 2018). Proceeding to direct screening
for pre-diabetes or diabetes has the potential to identify diabetes earlier and reduce the
risk of associated complications.
Marley and colleagues (Marley et al., 2015) suggest that a combination of point-ofcare (POC) and laboratory glycated haemoglobin A (HbA1C) testing is more effective
than IGT and/or IFG testing for diabetes in everyday practice in remote Aboriginal primary
health care. This method may simplify diabetes testing in remote areas, provide more
timely diagnoses, and increase case detection. Screening for type 2 diabetes with an
HbA1C or oral glucose tolerance test (OGTT) should be considered in Aboriginal and
Torres Strait Islander children aged 10 or older according to the presence of risk factors
(Peña et al., 2020).
A diabetes prediction model and tool published in 2015 (Adegbija et al., 2015) claims
to predict the 10-year absolute risk of type 2 diabetes for Aboriginal people based on
waist circumference (WC) and age. To date this work has not been replicated to assess
whether the findings can be generalised to Aboriginal and Torres Strait Islander
communities outside the Kimberley region of WA.
Education
It is recommended that education in diabetes prevention is tailored for Aboriginal and
Torres Strait Islander communities, families and individuals (Diabetes Australia, 2013a). It
needs to be delivered in a culturally appropriate manner and in the patient's native
language, with an interpreter where required (Nguyen et al., 2016). Awareness programs
and education programs (including school education programs) need to be communitywide, and culturally relevant, and communicate the fact that the onset of type 2 diabetes
can be delayed or possibly prevented (Australian Government Department of Health,
2021). Education should be provided in a culturally and linguistically appropriate manner,
which includes translating materials and services. They should also challenge the
perception that diabetes is ‘normal’ in Aboriginal and Torres Strait Islander communities
(Nguyen et al., 2016).
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Deadly Choices is a social marketing initiative that was started in 2010 in South East
Qld by the Institute for Urban Indigenous Health (IUIH). The Deadly Choices program
conducts school-based chronic disease education initiatives for young Aboriginal and
Torres Strait Islander students (years 7 to 12) in Brisbane, Qld (Institute for Urban
Indigenous Health, 2021; Malseed et al., 2014a).
It aims to empower Aboriginal and Torres Strait Islander peoples to make healthy
choices for themselves and their families, such as quitting smoking, eating good food,
and exercising daily. It also encourages people to access their local health service and
complete a 715 Health Check every 9-12 months - normalising the idea of seeing a
doctor not just when sick, but to remain healthy, access support, and prevent or better
manage chronic disease. An evaluation of the program found that participants
demonstrated significant improvements over time in knowledge, attitudes and selfefficacy associated with types of chronic disease, chronic disease risk factors, prevention
and health checks (Malseed et al., 2014b). The students who took part in the program
showed a significant improvement in their knowledge of chronic disease and associated
risk factors, and a significant increase in their breakfast frequency compared with a
control group.
Lifestyle modifications
Excess weight, suboptimal nutrition and physical inactivity are risk factors that contribute
to the disproportionately high levels of type 2 diabetes seen in Aboriginal and Torres
Strait Islander communities (Diabetes Australia, 2013a). Internationally, intensive lifestyle
programs have reduced the incidence of diabetes among people who are overweight with
pre-diabetes to an extent that is comparable to the use of medication (Closing the Gap
Clearinghouse, 2012). Whether similar programs would be effective for Aboriginal and
Torres Strait Islander people has yet to be established.
A review of healthy lifestyle programs addressing physical activity and nutrition
among Aboriginal and Torres Strait Islander people found that programs can have
positive health effects for up to two years, and are more likely to be effective if they are
initiated by the community (Closing the Gap Clearinghouse, 2012). However, without
adequate long-term funding, sustaining healthy lifestyle programs in communities where
multiple social and economic problems exist is particularly challenging, and very few
healthy lifestyle programs have to date continued to operate beyond five years (Closing
the Gap Clearinghouse, 2012; Diabetes Australia, 2013a; Seear et al., 2019).
In 2015, a lifestyle modification program designed to help people reduce their risk of
developing diabetes and cardiovascular disease, was funded by the Victorian
Government. Managed by Diabetes Australia - Victoria (Diabetes Victoria, 2021; Life!,
2015), the Life! program offers a course specifically for Aboriginal people and their
families called the Road to Good Health (The Life! Program, 2021). Run by Aboriginal
Health Workers and other health professionals, this course supports participants to make
long-term, sustainable lifestyle changes, such as adopting a healthier diet and becoming
more physically active. Anecdotal evidence suggests the course is culturally relevant,
valuable to users and popular, but published evaluations are not available.
Various programs have used sport to promote healthy lifestyles among Aboriginal and
Torres Strait Islander children and adults, but further studies are required to establish
their long-term impact (Closing the Gap Clearinghouse, 2012). Evaluation of short-term
programs have demonstrated some positive results, such as those reported in 12-week
exercise programs for Aboriginal and Torres Strait Islander males (Mendham et al., 2015)
and females (Canuto et al., 2012). The 10-week Too Deadly for Diabetes program
conducted in an urban Aboriginal community used diet and exercise to assist participants
to achieve positive health outcomes (Power et al., 2021). Much of the value of the
program was found in it being run by an Aboriginal person, for Aboriginal people and in
an Aboriginal organisation.
In the regional location of Derby, WA, the Derby Aboriginal Health Service ran a
lifestyle intervention program for young people aged 15-25 years with the aim of
preventing type 2 diabetes in high risk community members (Seear et al., 2019). An
education component was supported by gender-specific physical activity sessions. They
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concluded that programs involving community direction, a committed local person,
supportive facilitators and relevant and enjoyable content are likely to be useful but that
substantial, dedicated prevention funding over a long period of time is required.
Broader initiatives that extend beyond the immediate scope of the health sector have
also been proposed to help reduce the incidence of type 2 diabetes in the Aboriginal and
Torres Strait Islander population. They include (Diabetes Australia, 2013a; Pan et al.,
2021):
•

increasing availability, affordability and accessibility of healthy food and drinks
(e.g. in stores and through community gardens and traditional food projects)

•

limiting advertising of unhealthy food and drinks

•

providing clearer food labelling and education regarding the nutritional value of
foods

•

the provision of clean community water supply and water bubblers

•

use of taxation levers to reduce intake of sugary drinks (e.g. soft drinks)

•

encouraging physical activity through partnerships with local councils

•

improving housing.

Management
Providing appropriate, effective type 2 diabetes management for Aboriginal and Torres
Strait Islander people depends on: access to a broad range of health services in a broad
range of settings (Diabetes Australia, 2013a); and coordinated interaction between
people with diabetes and their families, communities, healthcare providers and the
healthcare system (Royal Australian College of General Practitioners, 2014).
Recommendations for improving type 2 diabetes management for Aboriginal and Torres
Strait Islander people include:
•

earlier detection of undiagnosed diabetes

•

good quality primary health care

•

access to medications

•

self-management education

•

tertiary specialist treatment when diabetes is complicated or complications
develop.

The following sections refer mainly to the management of type 2 diabetes for
Aboriginal and Torres Strait Islander people. Some information about managing diabetes
in pregnancy is also provided.
Managing diabetes in the primary health care setting
Improved diabetes management for Aboriginal and Torres Strait Islander people requires
access to a range of different models of culturally appropriate care (Diabetes Australia,
2013a) and involvement of an Aboriginal and Torres Strait Islander Health Worker, liaison
officer, outreach worker or care coordinator (Royal Australian College of General
Practitioners, 2014). A culturally safe, community level health-worker led model of
diabetes care for high risk patients can be effective in improving diabetes control in
remote Indigenous Australian communities (McDermott et al., 2015). It is also important,
however, to engage, educate and partner with patients to empower and enable them to
take the lead in their chronic condition management (Nguyen et al., 2016).
Up-skilling GPs to help them manage more complex patients, and providing access to
local services that offer specialised treatment (such as renal dialysis for those with
diabetes-related complications) would also contribute to improved diabetes management
(Diabetes Australia, 2013a). Timely diagnosis and an appropriate management plan,
optimal clinical treatment, and motivated self-care have been identified as key steps to
improved diabetes management and improved quality of life for the NT Aboriginal
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population (Li et al., 2019). Whyatt and colleagues (2017) suggest that timely
management in primary care for diabetes would improve preventive care, regular
monitoring, crisis intervention, and continuity of care, and reduce emergency department
presentations (Whyatt et al., 2017).
Previous research indicates that Aboriginal and Torres Strait Islander people with
diabetes in remote communities in the NT were presenting to hospitals in greater
numbers for diabetes care than at primary care establishments (Thomas et al., 2014).
However, a recent study found that initiation of a timely diabetes care plan was
associated with better short-term blood glucose control and fewer diabetes-related
admissions (Li et al., 2019).
Newer technology-based strategies have been shown to help facilitate diabetes
management in the primary care setting. For example:
•

shared electronic health records can reduce the risk of hospital admission for
diabetes because an Aboriginal patient’s medical history including current
medications and results of recent pathology are available at any health centre (Li
et al., 2019)

•

telemedicine addresses the distance barrier faced by remote Aboriginal and
Torres Strait Islander people with diabetes and mitigates the difficulties and costs
associated with coordinating a regular specialist visit to remote communities
(Nguyen et al., 2016).

Access to medicines
Australians living in areas of greater social disadvantage and in remote areas have
reduced initial access to newer diabetes medications (Morton 2021). Differential
prescribing of medications by remoteness and socioeconomic disadvantage has been
observed in Australia and may contribute to socioeconomic disparities in disease
outcomes (Hamrosi et al., 2006). Other potential barriers to access and use of medicines
by Aboriginal and Torres Strait Islander people include:
•

lack of transport and access to services

•

inability to afford medication and services

•

difficulty with storing medications, such as insulin, that require refrigeration

•

difficulty interpreting labelling and consumer medicine information

•

client beliefs and behaviour about filling scripts, taking medication, sharing
medication and side effects

•

lack of interpreters or culturally appropriate explanation of medications.

Self-management
Self-management and support for self-management is essential to managing diabetes
(Australian Government Department of Health, 2021b; Royal Australian College of
General Practitioners, 2014; Stoneman et al., 2014). The primary health system can
support Aboriginal and Torres Strait Islander people with diabetes through improved selfmanagement education, but the success of such programs is dependent on long-term
funding (Diabetes Australia, 2013a). There is evidence that culturally appropriate selfmanagement support for Aboriginal and Torres Strait Islander people is most effective
when led by Aboriginal and Torres Strait Islander Health Workers (Parmenter et al., 2020;
Stoneman et al., 2014). Other factors that contribute to the success of chronic disease
self-management programs for Aboriginal and Torres Strait Islander people include
(Parmenter et al., 2020):
•

a flexible manner that prioritises relationships

•

a social view of health that sees individual health as embedded in socio-cultural
contexts
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•

recognition of and a value for the cultural knowledge and connections of many
participants

•

provides empowerment and support for self-management and ownership of ones
own health.

Examples of culturally appropriate self-management support programs include the Aunty
Jean’s Good Health Team program (Illawarra Health, 2004), the Wurli-Wurlinjang Diabetes
Day program (Entwistle et al., 2011) and the Work It Out program (Parmenter et al., 2020).
Tertiary care
Tertiary specialist services are required to treat complex type 2 diabetes and the
complications of diabetes, but many Aboriginal and Torres Strait Islander people access
generalised diabetes care in hospitals (Diabetes Australia, 2013a; Whyatt et al., 2017).
Whyatt and colleagues observed that Aboriginal people with chronic disease use health
services in a different manner to non-Aboriginal people. High hospital use may be related
to primary care accessibility and poor continuity of care for chronic conditions. Admission
avoidance schemes such as, chronic disease management teams, outreach to local
primary health services and ambulatory telehealth services may help to re-direct or
address these disparities (Whyatt et al., 2017).
Although effective diabetes management requires high quality primary and secondary
care, affordable and timely access to tertiary specialist services is also required to treat
and manage complex diabetes and complications (Diabetes Australia, 2013a; Whyatt et
al., 2017). The Diabetes Australia Aboriginal and Torres Strait Islanders and diabetes
action plan (Diabetes Australia, 2013a) suggests that appropriate access to tertiary and
specialist services may be facilitated through investment in telehealth, and recommends
models of care that promote integration between the primary and tertiary care settings.
Managing diabetes in pregnancy and postpartum
The early detection and management of diabetes during pregnancy 6 is important to
reduce complications for both mothers and babies (Diabetes Australia, 2013a). The
increasing number of women developing GDM is putting great pressure on health
services, particularly the maternity hospitals where most women receive antenatal and
pregnancy care (Diabetes Australia, 2020). The increasing demand is leading to delays in
commencing management of GDM in some services, and care being delivered by
clinicians who lack appropriate training and expertise in GDM.
GDM detection and management in pregnancy and the postpartum period are also
important strategies for preventing or delaying the development of type 2 diabetes
(Campbell et al., 2017). However, barriers to screening that have been identified by
Aboriginal and Torres Strait Islander women include lack of awareness and forgetting
about the need for a test, test inconvenience (a two-hour test that requires the subject to
be in a fasted state), the unpleasant nature of the test and the fear of results, poor
communication, time pressures and costs. Additional psychological and motivational
barriers may also be present, such as denial, fear, tiredness, shame, stress, worry,
feelings that diabetes is inevitable and that women lack control over choices, lack of
belief in themselves and putting their own health last.
The Northern Territory Diabetes in Pregnancy Partnership Project, which commenced
in 2012, (Diabetes Australia, 2013a; Maple-Brown et al., 2013; Menzies School of Health
Research, 2015) has three key elements (Menzies School of Health Research, 2015):

6

•

a review of current models of care in the NT to improve health service delivery for
women with diabetes in pregnancy

•

development of a NT clinical register of referred patients for use by health
professionals

Diabetes in pregnancy refers to pre-existing diabetes and GDM.
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•

a detailed research project to assess rates and outcomes of diabetes in
pregnancy in the NT (Pregnancy and Adverse Neonatal Outcomes in Remote
Australia, PANDORA).

The project aims to contribute to the development of policy and planning for the
management of diabetes in pregnancy, and the follow-up of mother and baby, in urban,
rural and remote regions throughout Australia (Maple-Brown et al., 2013; Menzies School
of Health Research, 2015).

Programs and services
A range of mainstream and Aboriginal and Torres Strait Islander-specific Australian
Government Department of Health programs contribute to the prevention and
management of diabetes and other chronic conditions among Aboriginal and Torres Strait
Islander people at a national level (Department of Health, 2015b, 2015d). These
programs include:
• the Medicare Benefits Schedule (MBS) - The Medicare health assessment for
Aboriginal and Torres Strait Islander people (more commonly known as the
health check) must be performed by a medical practitioner and includes risk
assessments, diagnosis and intervention for common and treatable conditions
such as diabetes (Australian Government Department of Health, 2021a)
• the Practice Incentives Program - Indigenous Health Incentive (PIP IHI) was
reviewed and updated as part of the 2021-22 Federal Budget. It provides
incentive payments for general practices that register for the IHI and agree to
undertake specified activities to improve the provision of care to their Aboriginal
and/or Torres Strait Islander patients with a chronic disease (Services Australia,
2021)
• the Pharmaceutical Benefits Scheme (PBS) - provides subsidies for medicines
used in the treatment of diabetes (PBS medicine co-payments)
• the National Diabetes Services Scheme (NDSS) - provides subsidised diabetes
products and services to persons with diagnosed diabetes who are registered
with the scheme
• healthy lifestyle promotion programs including those that tackle smoking
• GP, specialist and allied health outreach services including the Indigenous
Australians’ Health Programme and Medical Outreach Indigenous Chronic
Disease Program
• funding for research into diabetes prevention among Aboriginal and Torres Strait
Islander people including: $3.87 million over three years from 2019-20 and 202122 for the Indigenous Youth Diabetes Models of Care project, which will develop,
pilot, evaluate and implement culturally appropriate models of care for Aboriginal
and Torres Strait Islander youth with type 2 diabetes; and $6 million over two
years from 2019-20 and 2020-21 for the Aboriginal and Torres Strait Islander
Diabetic Foot Complication Project, which aims to reduce diabetes foot-related
complications and amputations for Indigenous people (Australian Institute of
Health and Welfare, 2020c)
• the establishment of Primary Health Networks which work directly with GPs, other
primary care providers (including Aboriginal Community Controlled Health
Organisations), secondary care providers and hospitals to better coordinate care
across the local health system (Australian Institute of Health and Welfare, 2020c)
• the Insulin Pump Program which provides fully subsidised insulin pumps to
eligible, low income families who have children (up to 18 years of age) with type 1
diabetes and do not have access to other means of reimbursement, such as
private health insurance (Diabetes Australia, 2021c)

Published by Edith Cowan University, 2022

25

Journal of the Australian Indigenous HealthInfoNet, Vol. 3 [2022], Iss. 2, Art. 1

• funding for the Australian Institute of Health and Welfare (AIHW) to support
national surveillance and monitoring of vascular diseases including diabetes.
Back on Track is a collaboration between Diabetes Australia and the NDSS targeted
to Aboriginal and Torres Strait Islander people to encourage them to get ‘back on track’
with their diabetes self-care (Diabetes Australia, 2021a). The campaign has been
developed on the back of research which shows that during 2020, many Aboriginal and
Torres Strait Islander people disengaged from their routine diabetes and health care
management plans. The primary reasons for this were due to social distancing, fear of
exposure to COVID-19, and a focus on other priorities. The campaign encourages
patients to undergo routine, regular checkups with their doctor, health worker or nurse.
Primary health care services
At a local level, most mainstream and community controlled primary health care services
in Australia play a critical role in the delivery of diabetes care (Stoneman et al., 2014). To
meet the needs of Aboriginal and Torres Strait Islander people, primary health care
services need to deliver both competent and culturally appropriate chronic disease care
(Liaw et al., 2011). The involvement of Aboriginal and Torres Strait Islander Health
Workers has been identified by health professionals and patients as an important factor in
the delivery of good diabetes care to Aboriginal and Torres Strait Islander people
(McDermott et al., 2015; Stoneman et al., 2014). Aboriginal and Torres Strait Islander
Health Workers have been shown to help patients feel comfortable, help break down
communication and cultural barriers that may exist between patients and non-Indigenous
health staff (Stoneman et al., 2014), and provide culturally appropriate self-management
support (McDermott et al., 2015).
Aboriginal and Torres Strait Islander community controlled primary health care
services play a major role in delivering essential primary health care services to
Aboriginal and Torres Strait Islander people in a culturally secure manner (Australian
Institute of Health and Welfare, 2013).

Box 6: Aboriginal and Torres Strait Islander community controlled primary
health care services
Aboriginal and Torres Strait Islander community controlled primary health care
services are located in all jurisdictions and funded by the federal, state and territory
governments and other sources (Steering Committee for the Review of
Government Service Provision, 2014b). They are planned and governed by local
Aboriginal and Torres Strait Islander communities and aim to deliver holistic and
culturally appropriate health and healthrelated services.
Aboriginal and Torres Strait Islander community controlled primary health care
services vary in the primary health care activities they offer. Possible activities
include: diagnosis and treatment of illness or disease; management of chronic
illness; transportation to medical appointments; outreach clinic services;
immunisations; dental services; and dialysis services.

Policies and strategies
The Australian Government has recently released the Australian national diabetes
strategy 2021-2030 (Australian Government Department of Health, 2021b). An update on
the National Diabetes Strategy 2016-2020, the Strategy is based on contemporary
evidence and emerging priorities such as public health issues including COVID-19, aged
and disability care, mental health and Aboriginal and Torres Strait Islander health.
Development of the Strategy has been guided by an Expert Advisory Group and a
Jurisdictional Advisory Group and endorsed by Australian Health Ministers.
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As with the previous version, the Strategy includes seven high-level goals with areas
for action and measures of progress. The goals cover the important issues of prevention,
awareness, early detection and management of diabetes, as well as highlighting specific
vulnerable populations and the research agenda. Goal 5 is specific for reducing the
impact of diabetes among Aboriginal and Torres Strait Islander people, however actions
relating to all the goals will impact positively on this population (see Table 5).
Table 5. Components of the Australian national diabetes strategy 2021-2030

Vision
Strengthen, integrate and coordinate all sectors to improve health outcomes and reduce the
social and economic impact of diabetes in Australia
Principles
1. Facilitation of person-centred care and self-management throughout life
2. Reduction in health inequities
3. Collaboration and cooperation to improve health outcomes
4. Coordination and integration of diabetes care across services, settings, technology and
sectors
5. Measurement of health behaviours and outcomes
Goals
1. Prevent people developing type 2 diabetes
2. Promote awareness and earlier detection of type 1 and type 2 diabetes
3. Reduce the burden of diabetes and its complications and improve quality of life
4. Reduce the impact of pre-existing diabetes and gestational diabetes in pregnancy
5. Reduce the impact of diabetes among Aboriginal and Torres Strait Islander peoples
6. Reduce the impact of diabetes among other priority groups
7. Strengthen prevention and care through research, evidence and data
Selected national policy developments relevant to addressing diabetes among Aboriginal
and Torres Strait Islander people

1987

•

National Diabetes Service Scheme (NDSS) is established

1996

•
•

Diabetes becomes a National Health Priority Area (NHPA)
Ministerial Advisory Committee on Diabetes is established

1998

•

National diabetes strategy and implementation plan report is published

1999

•

National (insulin-treated) Diabetes Register (NDR) is established

2000

•

National diabetes strategy 2000-2004 is signed

2002

•

Australian Health Ministers’ Advisory Council (AHMAC) agreed to the
development of a national policy approach to chronic disease prevention and care

2006

•
•
•

National Service Improvement Framework for Diabetes is released
National chronic disease strategy is released
Australian Better Health Initiative is announced

2007

•
•

Diabetes is included in the National reform agenda
A national package to prevent type 2 diabetes is announced

2008

•
•

Australian type 2 diabetes risk assessment tool (AUSDRISK) is introduced
New Medicare item introduced to develop a Diabetes risk plan for high risk
individuals

Published by Edith Cowan University, 2022

27

Journal of the Australian Indigenous HealthInfoNet, Vol. 3 [2022], Iss. 2, Art. 1

•
•
•

Close the gap statement of intent is signed
National partnership agreement on closing the gap in Indigenous health outcomes
is established
Indigenous Chronic Disease Package is announced

2010

•

Practice Incentives Program-Indigenous Health Incentive (PIP-IHI) receives
funding

2011

•

NDSS introduces National Development Programs that include initiatives for
Aboriginal and Torres Strait Islander people

2013

•
•
•

Aboriginal and Torres Strait Islanders and diabetes action plan is released
National Aboriginal and Torres Strait Islander Health Plan 2013-2023 is released
Medical Outreach Indigenous Chronic Disease Program is established

2014

•

Indigenous Australians’ Health Programme is established

2015

•

National Diabetes Strategy 2016-2020 is released

2017

•

Diabetes in Australia: focus on the future is published

2019

•

National Agreement on Closing the Gap is developed

2021

•

National diabetes strategy 2021-2030 is released

Selected national policy developments relevant to addressing diabetes among
Aboriginal and Torres Strait Islander people are described briefly below:
•

The NDSS was established in 1987 (National Diabetes Services Scheme, 2022).
The NDSS is an initiative of the Federal Government administered by Diabetes
Australia. It provides diabetes-related products at subsidised prices and offers
information and support services to people with diabetes.

•

Diabetes first became a National Health Priority Area (NHPA) in 1996 (Australian
Institute of Health and Welfare & Commonwealth Department of Health and
Family Services, 1997) in recognition of the impact that diabetes has on the
Australian community, and in order to give it a higher profile in the health system.

•

In the same year the Federal Minister for Health and Family Services announced
the establishment of the Ministerial Advisory Committee on Diabetes to provide
the Government with independent advice on the management of diabetes in
Australia (Colagiuri et al., 1998). The National diabetes strategy and
implementation plan, published in 1998, included recognition that Aboriginal and
Torres Strait Islander people would require special consideration in the planning,
delivery and coordination of diabetes prevention and care services.

•

In 1999, the NDR was established. The NDR is a database that aims to monitor
the incidence of Australians who use insulin to treat diabetes. It includes people
with type 1, insulin-treated type 2, gestational and other types of diabetes. Data
for the NDR are sourced from the NDSS Registrant data, the NDSS Sales data,
the Australasian Paediatric Endocrine Group’s (APEG) state-based registers and
the National Death Index (NDI) (Australian Institute of Health and Welfare,
2020d).

•

In the year 2000, all Australian health ministers signed the National diabetes
strategy 2000-2004 (Diabetes Australia, 2013c). It aimed to help reduce the
personal and public burden of diabetes in Australia (Commonwealth Department
of Health and Aged Care, 1999). The Strategy identified five goals and a
framework for action. Aboriginal and Torres Strait Islander people were identified
as a high-risk population who would require specific attention.

•

In 2002, AHMAC agreed to the development of a national policy approach to
chronic disease prevention and care (National Health Priority Action Council,
2006). This led to the development of the National Service Improvement
Frameworks (one of which is for diabetes) (National Health Priority Action
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Council, 2005), followed by the National chronic disease strategy in 2006
(National Health Priority Action Council, 2006) and a blueprint for a national
surveillance system (Department of Health, 2015c). There was an emphasis on
improving access to services for Aboriginal and Torres Strait Islander people in
each of these initiatives.
•

In 2007, diabetes was included in the ‘human capital’ stream of the National
reform agenda. The Federal Government provided funding over four years for a
national package to prevent type 2 diabetes (National Partnership Agreement on
Preventive Health Implementation Working Group, 2009).

•

A diabetes risk assessment tool (the AUSDRISK tool) was developed in 2008,
that predicts the five year risk of type 2 diabetes (Department of Health, 2015a).
The AUSDRISK is suitable for use in high risk populations, including Aboriginal
and Torres Strait Islander populations (Department of Health, 2015a).

•

In 2008, the Government and Opposition signed the Close the gap statement of
intent (Human Rights and Equal Opportunity Commission, 2008), committing to
closing the health and life expectancy gap between Aboriginal and Torres Strait
Islander people and other Australians by 2030. By the end of 2010, most state
and territory governments and oppositions had also signed the Statement
(Holland, 2015).

•

In 2009:
•

all Australian governments committed to achieving the Closing The Gap
targets in the National Indigenous reform agreement (Closing the gap)
(Council of Australian Governments, 2009a)

•

COAG also agreed to the National partnership agreement on closing the
gap in Indigenous health outcomes (Council of Australian Governments,
2009b)

•

the Federal Government committed funding to the Indigenous Chronic
Disease Package (ICDP) (Department of Health, 2012)

•

the Federal Government's Implementation plan (Commonwealth of
Australia, 2009) was endorsed by the Australian Health Ministers'
Conference (Macklin, 2010).

•

The Practice Incentives Program-Indigenous Health Incentive (PIP-IHI) commenced
in 2010 (Couzos & Thiele, 2010). Funding was allocated over four years to support
primary health care services to provide better health care for Aboriginal and Torres
Strait Islander people, including best practice management of chronic disease
(Couzos & Thiele, 2010; Department of Health and Ageing, 2013).

•

In 2013, Diabetes Australia released the Aboriginal and Torres Strait Islanders
and diabetes action plan (Diabetes Australia, 2013a) - the first national policy
document specific to diabetes in the Aboriginal and Torres Strait Islander
population.

•

The National Aboriginal and Torres Strait Islander Health Plan 2013-2023 (the
Health plan) was also released in 2013 (Holland, 2015). This evidence-based
policy framework was developed to guide policies and programs to improve
Aboriginal and Torres Strait Islander health (Australian Department of Health,
2015b). The Health plan (Australian Department of Health and Ageing, 2013)
makes specific reference to the impact of chronic diseases, including diabetes, on
the health of Aboriginal and Torres Strait Islander adults.

•

In 2013, the Medical Outreach Indigenous Chronic Disease Program was
established by the Australian Government through the consolidation of two
existing Indigenous chronic disease outreach programs.

•

The Indigenous Australians’ Health Programme (IAHP) was established in 2014,
consolidating four existing Aboriginal and Torres Strait Islander health funding
streams including the Aboriginal and Torres Strait Islander chronic disease fund
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(which replaced the ICDP) (Australian Government Department of Health,
2021d). The IAHP provides some funding for chronic disease management,
including the Medical Outreach Indigenous Chronic Disease Program.
•

The Australian National Diabetes Strategy 2016-2020 was released at the end of
2015 (Australian Department of Health, 2015a). It outlined a national response to
diabetes, incorporating seven high-level goals with potential areas for action and
measures of progress. Goal 5 aimed to reduce the impact of diabetes among
Aboriginal and Torres Strait Islander people (Australian Health Ministers’ Advisory
Council, 2017).

•

Diabetes in Australia: focus on the future is the implementation plan (the Plan)
developed to operationalise each of the Strategy’s seven goals. Developed in
partnership between the Australian Government and all state and territory
governments, the Plan was published in 2017 (Australian Health Ministers’
Advisory Council, 2017). The Plan identified nine areas where national priority
action is required. Updated data was published in 2020 (Australian Institute of
Health and Welfare, 2020c).

•

The National Agreement on Closing the Gap was developed in 2019-2020 in
partnership between Australian Governments and Aboriginal and Torres Strait
Islander peak organisations. It sets out new targets and Priority Reforms to
improve life outcomes experienced by Indigenous Australians (Coalition of Peaks,
2020).

•

The Australian national diabetes strategy 2021-2030 was released at the end of
2021 (Australian Government Department of Health, 2021b). It supercedes the
2016-2020 Strategy and will be followed by an Implementation Plan. It is
anticpated that a mid-term review will be undertaken in 2025.

Future directions
The health care needs of Aboriginal and Torres Strait Islander people with chronic
conditions are often complex and managed in a cross-cultural context (Schmidt et al.,
2016). Aboriginal and Torres Strait Islander Health Workers and Practitioners are
important members of multidisciplinary primary health care teams in Aboriginal and
Torres Strait Islander communities in Australia, due to their knowledge of community and
culture and, when trained in diabetes care and management, are able to provide regular
health checks and education about health risks and self-management. Increased support
and training opportunities for Indigenous Health Workers, and the workforce working with
and within Aboriginal and Torres Strait Islander primary care settings is essential. But
placing skilled and dedicated IHWs to improve care coordination is insufficient to improve
chronic disease outcomes without a supportive and systematic service delivery system.
The Australian national diabetes strategy 2021-2030 highlights key issues that require
special attention including diabetes in aged care, prevention of type 2 diabetes, and diabetes
in vulnerable communities including Aboriginal and Torres Strait Islander communities.
However, the gap between Aboriginal and Torres Strait Islander people and non-Indigenous
people is not closing. Experts are calling for a National Type 2 Diabetes Prevention Program
with collaboration from all levels of government (Diabetes Australia, 2021b).

Concluding comments
The high levels of type 2 diabetes in many Aboriginal and Torres Strait Islander
communities reflect a broad range of historical, social and cultural determinants, and the
contribution of lifestyle and other health risk factors (Closing the Gap Clearinghouse,
2012; Diabetes Australia, 2013a; O'Dea et al., 2007). Emerging evidence suggests that
epigenetic factors, the intrauterine environment and other early life factors may also
influence the development of diabetes (McEwen et al., 2019; Zimmet et al., 2014).
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There is growing concern regarding the emergence of type 2 diabetes in Aboriginal
and Torres Strait Islander children and adolescents (Zimmet et al., 2014). Early onset of
type 2 diabetes places these adolescents at heightened risk of comorbidities, diabetes
complications and associated premature mortality (Maple-Brown et al., 2010; Peña et al.,
2020; Titmuss et al., 2019; Viner et al., 2017).
The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) virus and the resulting COVID-19 pandemic (Gujral et al., 2020) has highlighted the
vulnerability of people with diabetes and other non-communicable chronic diseases
(Australian Government Department of Health, 2021b). The Australian Government
advises that Aboriginal and Torres Strait Islander people may be at a greater risk of
severe illness from COVID-19 (Australian Government Department of Health, 2021c)
than the general population.
The Australian Government has recently released the Australian national diabetes
strategy 2021-2030 (Australian Government Department of Health, 2021b). The Strategy
is based on contemporary evidence and emerging priorities such as public health issues
including COVID-19, aged and disability care, mental health and Aboriginal and Torres
Strait Islander health. It is hoped that the Strategy will provide a bi-partisan long-term
commitment to culturally appropriate prevention and management of type 2 diabetes
across the lifespan for Aboriginal and Torres Strait Islander people.
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Appendix 1: data sources, limitations and methods
The statistical information provided in this review draws on data from a number of
sources. The various limitations associated with the data are discussed briefly below:
Defining diabetes
Reported statistics on diabetes prevalence, incidence, health service utilisation, mortality
and burden of disease may not clearly define which type (or combination of types) of
diabetes is being analysed. Care should be taken to avoid assumptions and
generalisations.
Prevalence
People who develop diabetes are often unaware they have the condition, and surveys
that do not medically verify self-reported data may underestimate the true prevalence of
diabetes (Australian Institute of Health and Welfare, 2011).
Incidence
The National (insulin-treated) diabetes register (NDR) collects information on new cases
of insulin-treated diabetes. The NDR may underestimate the number of Aboriginal and
Torres Strait Islander people with insulin-treated diabetes resulting from non-identification
of people of Aboriginal or Torres Strait Islander origin. Underestimates may also be due
to low levels of registration with the NDSS, as Aboriginal and Torres Strait Islander
people can access diabetes services and products through other programs (this is
particularly true in rural and remote areas) (Australian Institute of Health and Welfare,
2014c).
The incidence of type 2 diabetes not requiring insulin treatment cannot be estimated
with accuracy due to gaps in currently available data (Australian Institute of Health and
Welfare, 2015e).
Hospitalisations
Hospitalisation figures are for ‘separations’, and as there can be multiple separations for
the same individual, hospital records do not necessarily reflect the prevalence of a
disease in the population (Steering Committee for the Review of Government Service
Provision, 2014a).
Mortality
Indigenous status may be under-identified in death data. Death data for Aboriginal and
Torres Strait Islander people is typically only available for NSW, Qld, WA, SA and the NT,
as these jurisdictions have sufficient levels of identification and sufficient numbers of
deaths to support analysis (Australian Bureau of Statistics, 2015; Steering Committee for
the Review of Government Service Provision, 2014a).
Death data probably underestimates deaths due to diabetes as the condition is
frequently under-reported on death certificates or not recorded as the underlying cause of
death (International Diabetes Federation, 2013).
Burden of disease
The Australian burden of disease study uses the underlying cause of death to calculate
estimates of fatal burden (Australian Institute of Health and Welfare, 2015a). Use of the
underlying cause of death alone (without consideration of associated causes) cannot
reflect more complex situations where more than one disease contributes to death.
Diabetes is often associated with other diseases and listed as an associated cause of
death; therefore burden of disease estimates may not reflect the total fatal burden of
diabetes.
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